Garrett Bourne is currently undertaking the Tinsley Harrison Internal Medicine Residency Program at the University of Alabama at Birmingham. He attended Brigham Young University for his undergraduate degree in biochemistry before completing medical school at Dell Medical School at the University of Texas, Austin. After completing residency, he plans to pursue fellowship training in hematology/oncology. He has a particular interest in hematologic malignancies.

Ravi Bhatia is a distinguished professor of hematology and oncology and the Director of the Stem Cell Program at the School of Medicine, the University of Alabama at Birmingham. He completed his MD at the All-India Institute of Medical Sciences and gained his hematology and oncology and bone marrow transplant training at the University of Minnesota. His clinical interests include hematologic malignancies and hematopoietic cell transplantation, with an emphasis on myeloid leukemias. His research focuses on studying the regulation of normal and malignant hematopoietic stem cells, therapeutic targeting of malignant stem cells and hematopoietic stem cell therapeutics. He is a scholar of the Leukemia and Lymphoma Society and is an elected member of the American Society of Clinical Investigation and the Association of American Physicians.

Omer Jamy is currently an associate professor of medicine in the Division of Hematology/Oncology at the University of Alabama at Birmingham, USA. He completed his MD at Aga Khan University in 2012 and his internal medicine residency at the University of Tennessee in Memphis, followed by fellowship training in hematology/oncology and bone marrow transplantation and cellular therapy at the University of Alabama at Birmingham. His clinical and research interests include myeloid malignancies (acute myeloid leukemia, myelodysplastic syndrome, chronic myeloid leukemia and myelofibrosis), acute lymphoblastic leukemia and allogeneic stem cell transplantation.